The Inflammation Pathway from Cholesterol to Aging (Mobile)

Overview:

The Inflammation Pathway from Cholesterol to Agingpowered by Skyscape Publisher: S.O.T.A. Technologies, Inc. Dr. Sota Omoigui explores the relationship between inflammatory processes and the development of diseases associated with aging. He also proposes potential new drugs that could mitigate these disease processes. Dr. Omoigui focuses on how production of cholesterol by the liver leads to activation of a specific inflammatory pathway. He then discusses how this pathway may affect many disease processes including those affecting the cardiovascular, neuromuscular and endocrine systems and more.Dr. Omoigui identifies how statins and bisphosphonate medications block a minor branch of this inflammatory pathway. He then identifies a number of plant compounds that he believes could form the basis for a new drug roadmap that may ultimately prove to be more effective than statins.Key FeaturesInformation on the mechanism by which statins and bisphosphonate medications help block an inflammatory pathway. Dr. Sota Omoigui''s perspective regarding a road map for potential new drugs that rely on plant-based compounds and which may ultimately prove to block this inflammation pathway more effectively than today''s statin medications.Additionally, you''ll get valuable added features, available only from Skyscape:New interactive flowchart: Complex algorithms and protocols are transformed from static images into dynamic step-by-step decision support tools. This innovative feature can quickly and easily walk you through even the most intricate decision models.View flowchart demo> Full Image: Vivid images that aid in diagnostic workup.Plus, with Skyscape''s powerful SmartLink cross-linking capability you can quickly and easily access any related disease and diagnostic topics across your entire mobile reference library.

(Is this item miscategorized? Does it need more tags? Let us know.)